Pacific Biosciences Of California Inc Asset Turnover Ratio (PACB), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Pacific Biosciences Of California Inc   (NASDAQ: PACB)
 

Pacific Biosciences Of California Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Pacific Biosciences Of California Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.2 in the first quarter (Mar 31 2026)

Within sector 13 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 1763 to 2535.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PACB Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -8.93 % -37 % -44.04 % -44.57 % -47.52 %
Y / Y Revenue Change 0.58 % 13.75 % -2.83 % 10.42 % -4.32 %
Asset Turnover Ratio (TTM) 0.2 0.2 0.17 0.14 0.12
PACB's Total Ranking # 2535 # 1763 # 2104 # 2252 # 2941
Seq. Asset Change -0.21 % -2.18 % -2.7 % -4.1 % -30.97 %
Seq. Revenue Change -19.15 % 20.22 % -4.49 % 8.34 % -8.56 %



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 14
Healthcare Sector # 362
Overall Market # 2535

Asset Turnover Ratio Statistics
High Average Low
21.34 9.11 4.92
(Jun 30 2015)   (Dec 31 2025)




PACB Company Profile • Back to PACB Efficiency Comparisons • Compare PACB Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Catalyst Pharmaceuticals Inc   0.56 $ 596.958  Millions$ 1,068.777  Millions
Pacira Biosciences inc   0.55 $ 734.864  Millions$ 1,327.073  Millions
Baxter International Inc   0.55 $ 11,320.000  Millions$ 20,503.500  Millions
Alkermes Plc   0.55 $ 1,562.300  Millions$ 2,831.848  Millions
Bruker Corporation  0.55 $ 3,457.300  Millions$ 6,286.700  Millions
Avantor Inc   0.55 $ 6,552.200  Millions$ 11,977.625  Millions
Integer Holdings Corporation  0.55 $ 1,854.663  Millions$ 3,397.635  Millions
Haemonetics Corporation  0.54 $ 1,333.586  Millions$ 2,447.766  Millions
Scientific Industries Inc   0.54 $ 6.588  Millions$ 12.124  Millions
Soleno Therapeutics Inc  0.54 $ 285.008  Millions$ 526.105  Millions
Supernus Pharmaceuticals inc   0.54 $ 776.833  Millions$ 1,438.883  Millions
Stryker Corp  0.54 $ 25,270.000  Millions$ 46,880.750  Millions
Charles River Laboratories International inc   0.54 $ 4,027.044  Millions$ 7,485.022  Millions
Lifecore Biomedical Inc   0.53 $ 125.080  Millions$ 234.434  Millions
Cvrx inc   0.53 $ 57.909  Millions$ 108.853  Millions
Enovis Corp  0.53 $ 2,275.853  Millions$ 4,280.440  Millions
Icu Medical Inc  0.53 $ 2,156.379  Millions$ 4,068.639  Millions
Bridgebio Pharma Inc   0.53 $ 579.958  Millions$ 1,096.362  Millions
Artivion Inc   0.53 $ 458.098  Millions$ 866.000  Millions
Intuitive Surgical Inc   0.53 $ 10,582.100  Millions$ 20,021.175  Millions
Bristol myers Squibb Company  0.53 $ 48,482.000  Millions$ 92,019.750  Millions
Brookdale Senior Living Inc   0.52 $ 3,145.058  Millions$ 6,001.057  Millions
Gilead Sciences Inc   0.52 $ 29,736.000  Millions$ 57,388.750  Millions
Clearpoint Neuro Inc   0.52 $ 40.614  Millions$ 78.597  Millions
Merck and Co Inc   0.51 $ 65,768.000  Millions$ 128,155.000  Millions
Carlsmed Inc   0.51 $ 55.386  Millions$ 109.256  Millions
Novavax inc   0.50 $ 596.338  Millions$ 1,184.028  Millions
Ultragenyx Pharmaceutical Inc   0.50 $ 669.708  Millions$ 1,331.178  Millions
Amgen Inc   0.50 $ 45,369.000  Millions$ 90,282.000  Millions
Cryo cell International Inc   0.50 $ 31.281  Millions$ 62.555  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.